Cognitive Symptom: Clinical Trials

1 trial for Cognitive Symptom, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Cognitive Symptom: new trials by email Literature Review of Cognitive Symptom trials Research Report on Cognitive Symptom

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
Niagen - Covid19, Sequelae of; Infection
Phase 4CompletedMassachusetts General Hospital722021-08-282025-08-05

Narrower conditions

COVID-19 (1)  ·  Infections (1)  ·  Neurobehavioral Manifestations (1)  ·  Post-Acute COVID-19 Syndrome (1)

Broader conditions

Chronic Disease (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Disease Attributes (1)  ·  Lung Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  Post-Infectious Disorders (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)

Interventions

Niacinamide (1)  ·  nicotinamide-beta-riboside (1)

Sponsors

Massachusetts General Hospital (1)

Countries

United States (1)

Top investigators

Edmarie Guzman-Velez, PhD (1)

Results publications

PMID 41357333